{"entity":{"type":"insider","cik":"0001619294","url":"/insider/0001619294","json_url":"/insider/0001619294.json","name":"Woiwode Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":15,"first":"2016-07-25","last":"2022-05-03","span_basis":"filed_date"},"name_variants":[{"name":"Woiwode Thomas","source":"filing","n_filings":15,"first_seen":"2016-07-25","last_seen":"2022-05-03"}],"transactions":[{"id":6713973,"accession":"0000899243-22-016387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016387","line_url":"/filing/0000899243-22-016387#line-1","is_derivative":false,"issuer_cik":"0001544227","issuer_name":"Tempest Therapeutics, Inc.","issuer_ticker":"TPST","issuer_name_source":null,"issuer_url":"/issuer/0001544227","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2118644.0,"shares_display":"2,118,644","price_per_share":2.36,"price_display":"2.36","price_state":"stated","total_value":4999999.84,"total_display":"4,999,999.84","total_whole":"5,000,000","shares_owned_after":2118644.0,"shares_owned_after_display":"2,118,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-03","scope":"insider"},{"id":5363000,"accession":"0000899243-21-000160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-000160","line_url":"/filing/0000899243-21-000160#line-1","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"Gritstone Oncology, Inc.","issuer_ticker":"GRTS","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1347709.0,"shares_display":"1,347,709","price_per_share":3.71,"price_display":"3.71","price_state":"stated","total_value":5000000.39,"total_display":"5,000,000.39","total_whole":"5,000,000","shares_owned_after":1347709.0,"shares_owned_after_display":"1,347,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2021-01-04","scope":"insider"},{"id":3106876,"accession":"0001567619-20-018012","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001567619-20-018012","line_url":"/filing/0001567619-20-018012#line-6","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"Aligos Therapeutics, Inc.","issuer_ticker":"ALGS","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":862444.0,"shares_owned_after_display":"862,444","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-20","scope":"insider"},{"id":3255252,"accession":"0001209191-20-015661","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-015661","line_url":"/filing/0001209191-20-015661#line-4","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4050000.0,"total_display":"4,050,000.00","total_whole":"4,050,000","shares_owned_after":933352.0,"shares_owned_after_display":"933,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":2643956,"accession":"0001209191-20-015670","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-015670","line_url":"/filing/0001209191-20-015670#line-4","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":null,"owner_name":"Versant Ventures VI GP, L.P.; Versant Vantage I GP, L.P.; Versant Vantage I GP-GP, LLC; Versant Venture Capital VI, L.P.; Versant Ventures VI GP-GP, LLC; Woiwode Thomas; Versant Vantage I, L.P.","owner_display_name":"Versant Ventures VI GP, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":225000.0,"shares_display":"225,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4050000.0,"total_display":"4,050,000.00","total_whole":"4,050,000","shares_owned_after":933352.0,"shares_owned_after_display":"933,352","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-03","scope":"insider"},{"id":6467025,"accession":"0000899243-18-013239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-013239","line_url":"/filing/0000899243-18-013239","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44000.0,"shares_display":"44,000","price_per_share":57.987272727272725,"price_display":"57.99","price_state":"stated","total_value":2551440.0,"total_display":"2,551,440.00","total_whole":"2,551,440","shares_owned_after":641014.0,"shares_owned_after_display":"641,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-17","scope":"insider","n_lines":2},{"id":6887683,"accession":"0000899243-18-012101","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-18-012101","line_url":"/filing/0000899243-18-012101#line-9","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1653.0,"shares_display":"1,653","price_per_share":51.45,"price_display":"51.45","price_state":"stated","total_value":85046.85,"total_display":"85,046.85","total_whole":"85,047","shares_owned_after":5629.0,"shares_owned_after_display":"5,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-08","filed_date":"2018-05-09","scope":"insider"},{"id":6887680,"accession":"0000899243-18-012101","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-012101","line_url":"/filing/0000899243-18-012101","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119709.0,"shares_display":"119,709","price_per_share":50.37905036379888,"price_display":"50.38","price_state":"stated","total_value":6030825.74,"total_display":"6,030,825.74","total_whole":"6,030,826","shares_owned_after":1199784.0,"shares_owned_after_display":"1,199,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider","n_lines":8},{"id":6772897,"accession":"0000899243-18-011133","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-011133","line_url":"/filing/0000899243-18-011133","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30566.0,"shares_display":"30,566","price_per_share":50.289142184126156,"price_display":"50.29","price_state":"stated","total_value":1537137.92,"total_display":"1,537,137.92","total_whole":"1,537,138","shares_owned_after":1297334.0,"shares_owned_after_display":"1,297,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-30","filed_date":"2018-05-02","scope":"insider","n_lines":4},{"id":6593200,"accession":"0000899243-18-010983","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-010983","line_url":"/filing/0000899243-18-010983","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11648.0,"shares_display":"11,648","price_per_share":50.02192822802198,"price_display":"50.02","price_state":"stated","total_value":582655.42,"total_display":"582,655.42","total_whole":"582,655","shares_owned_after":1324194.0,"shares_owned_after_display":"1,324,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-27","filed_date":"2018-04-30","scope":"insider","n_lines":4},{"id":6593192,"accession":"0000899243-18-010983","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-010983","line_url":"/filing/0000899243-18-010983","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210610.0,"shares_display":"210,610","price_per_share":50.110543611414464,"price_display":"50.11","price_state":"stated","total_value":10553781.59,"total_display":"10,553,781.59","total_whole":"10,553,782","shares_owned_after":1334430.0,"shares_owned_after_display":"1,334,430","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-26","filed_date":"2018-04-30","scope":"insider","n_lines":4},{"id":6407389,"accession":"0000899243-18-010841","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-010841","line_url":"/filing/0000899243-18-010841","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22841.0,"shares_display":"22,841","price_per_share":50.98968521518322,"price_display":"50.99","price_state":"stated","total_value":1164655.4,"total_display":"1,164,655.40","total_whole":"1,164,655","shares_owned_after":1519505.0,"shares_owned_after_display":"1,519,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-24","filed_date":"2018-04-26","scope":"insider","n_lines":4},{"id":6407378,"accession":"0000899243-18-010683","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-18-010683","line_url":"/filing/0000899243-18-010683","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101994.0,"shares_display":"101,994","price_per_share":50.6784844206522,"price_display":"50.68","price_state":"stated","total_value":5168901.34,"total_display":"5,168,901.34","total_whole":"5,168,901","shares_owned_after":1539576.0,"shares_owned_after_display":"1,539,576","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-23","filed_date":"2018-04-24","scope":"insider","n_lines":4},{"id":4069494,"accession":"0000899243-17-029615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-029615","line_url":"/filing/0000899243-17-029615#line-1","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3059.0,"shares_display":"3,059","price_per_share":20.2911,"price_display":"20.29","price_state":"stated","total_value":62070.4749,"total_display":"62,070.47","total_whole":"62,070","shares_owned_after":4959.0,"shares_owned_after_display":"4,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":5052111,"accession":"0000899243-17-027487","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-027487","line_url":"/filing/0000899243-17-027487#line-2","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.24,"price_display":"20.24","price_state":"stated","total_value":4048.0,"total_display":"4,048.00","total_whole":"4,048","shares_owned_after":8018.0,"shares_owned_after_display":"8,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-27","filed_date":"2017-11-28","scope":"insider"},{"id":5052107,"accession":"0000899243-17-027487","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-027487","line_url":"/filing/0000899243-17-027487#line-1","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":20.2105,"price_display":"20.21","price_state":"stated","total_value":34357.85,"total_display":"34,357.85","total_whole":"34,358","shares_owned_after":8218.0,"shares_owned_after_display":"8,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-24","filed_date":"2017-11-28","scope":"insider"},{"id":2596262,"accession":"0001104659-16-163805","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001104659-16-163805","line_url":"/filing/0001104659-16-163805","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161000.0,"shares_display":"161,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":2254000.0,"total_display":"2,254,000.00","total_whole":"2,254,000","shares_owned_after":4104045.0,"shares_owned_after_display":"4,104,045","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-10-24","filed_date":"2016-12-23","scope":"insider","n_lines":4},{"id":3044803,"accession":"0001209191-16-133852","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-16-133852","line_url":"/filing/0001209191-16-133852","is_derivative":false,"issuer_cik":"0001619294","issuer_name":"Audentes Therapeutics, Inc.","issuer_ticker":"BOLD","issuer_name_source":null,"issuer_url":"/issuer/0001619294","owner_cik":"0001619294","owner_name":"Woiwode Thomas","owner_display_name":"Woiwode Thomas","owner_url":"/insider/0001619294","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":525000.0,"total_display":"525,000.00","total_whole":"525,000","shares_owned_after":1795524.0,"shares_owned_after_display":"1,795,524","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-25","filed_date":"2016-07-25","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001544227","name":"Tempest Therapeutics, Inc.","url":"/issuer/0001544227","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2022-05-03","last_seen":"2022-05-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001656634","name":"Gritstone Oncology, Inc.","url":"/issuer/0001656634","role":"Director","n_filings":1,"first_seen":"2021-01-04","last_seen":"2021-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001799448","name":"Aligos Therapeutics, Inc.","url":"/issuer/0001799448","role":"Director","n_filings":1,"first_seen":"2020-10-20","last_seen":"2020-10-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-03-03","last_seen":"2020-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director","n_filings":9,"first_seen":"2016-12-23","last_seen":"2018-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001628738","name":"Audentes Therapeutics, Inc.","url":"/issuer/0001628738","role":"Director","n_filings":1,"first_seen":"2016-07-25","last_seen":"2016-07-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001619294","retrieved_at":"2026-08-22T07:27:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}